Weill Cornell Medicine and the Cornell Jeb E. Brooks School of Public Policy have established the Cornell Health Policy Center to serve as the locus for health policy impact, research and training across Cornell.
Weill Cornell Medicine researchers have determined the full-length structure and function of a blood pressure-regulating hormone receptor, which may enable better drug targeting of the receptor for diseases such as hypertension and heart failure.
A Cornell-led team will use a $2 million National Science Foundation grant to develop a “microbe-mineral atlas,” a catalog of microorganisms and how they interact with minerals, key for mining critical metals used for generating sustainable energy.
The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and smarter through virtual screening, according to Weill Cornell Medicine researchers.
Weill Cornell Medicine researchers have received a five-year, $6.2 million grant from the National Institute on Aging, part of the National Institutes of Health, to build a portable, high-resolution Positron Emission Tomography scanner that can detect the earliest stages of Alzheimer’s disease.
Dr. Chani Traube, professor of pediatrics at Weill Cornell Medicine, has been awarded a $3.4 million grant from the National Institutes of Health for a clinical trial called Optimizing Pain Treatment in Children on Mechanical ventilation.
Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells – blocking the energy supply T cells depend on. The work points toward a promising new immunotherapy approach for ovarian cancer.
A new system can accurately assess the chromosomal status of in vitro-fertilized embryos using only time-lapse video images of the embryos and maternal age, according to a study from investigators at Weill Cornell Medicine.
